Primary isolated bone marrow diffuse large B cell lymphoma with long-term complete remission Fulltext Access 5 Pages 2018
Marking of definitive HSC precursors in E7.5-E8.5 embryos using an Abcg2-CreER lineage-tracing mouse model Fulltext Access 5 Pages 2018
Physicians' knowledge and attitudes in Saudi Arabia regarding implantable cardiac defibrillators Fulltext Access 5 Pages 2018
Enzyme replacement therapy reverses B lymphocyte and dendritic cell dysregulations in patients with Gaucher Disease Fulltext Access 5 Pages 2018
Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene Fulltext Access 5 Pages 2018
A novel approach using ancillary tests to guide treatment of Glanzmann thrombasthenia patients undergoing surgical procedures Fulltext Access 5 Pages 2018
A rare case of a minimally secretory plasma cell leukemia with a hemorrhagic gastric plasmacytoma Fulltext Access 5 Pages 2018
Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases Fulltext Access 5 Pages 2018
Generation of induced pluripotent stem cells, KCi001-A derived from a Bardet-Biedl syndrome patient compound heterozygous for the BBS1 variants c.1169T>G/c.1135G>C Fulltext Access 5 Pages 2018
Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab Fulltext Access 5 Pages 2018
Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience Fulltext Access 5 Pages 2018
High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype Fulltext Access 5 Pages 2018
Monitoring of clonal evolution of double C-KIT exon 17 mutations by Droplet Digital PCR in patients with core-binding factor acute myeloid leukemia Fulltext Access 5 Pages 2018
Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML Fulltext Access 5 Pages 2018
A phase 1 study of chemosensitization with plerixafor plus G-CSF in adults with relapsed acute myeloid leukemia Fulltext Access 5 Pages 2018
Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation Fulltext Access 5 Pages 2018
Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia, Brazil Fulltext Access 5 Pages 2018
Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A) Fulltext Access 5 Pages 2018
Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B Fulltext Access 5 Pages 2018
Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy Fulltext Access 5 Pages 2018
Generation and characterization of eight human-derived iPSC lines from affected and unaffected THAP1 mutation carriers Fulltext Access 5 Pages 2018
Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1 Fulltext Access 5 Pages 2018
Generation of induced pluripotent stem cells, KCi002-A derived from a patient with Bardet-Biedl syndrome homozygous for the BBS10 variant c.271insT Fulltext Access 5 Pages 2018
Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation Fulltext Access 5 Pages 2018
Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect Fulltext Access 5 Pages 2018
Roscoe O. Brady: Physician whose pioneering discoveries in lipid biochemistry revolutionized treatment and understanding of lysosomal diseases Fulltext Access 5 Pages 2018
Generation of CSi001-A, a transgene-free, induced pluripotent stem cell line derived from a Parkinson Disease (PD) patient Fulltext Access 5 Pages 2018
Predicted S and s phenotypes from genotyping results among Thai populations to prevent transfusion-induced alloimmunization risks Fulltext Access 5 Pages 2018
Ultrastructural changes in peripheral blood leukocytes in α-synuclein knockout mice Fulltext Access 5 Pages 2018
Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50 Fulltext Access 5 Pages 2018
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 Fulltext Access 5 Pages 2018
Generation of two iPSC lines (IMGTi001-A and IMGTi001-B) from human skin fibroblasts with ring chromosome 22 Fulltext Access 5 Pages 2018
Generation of induced pluripotent stem cells from a patient with X-linked juvenile retinoschisis Fulltext Access 5 Pages 2018
Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation Fulltext Access 5 Pages 2018
Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line Fulltext Access 5 Pages 2018
Generation and characterization of two human iPSC lines from patients with methylmalonic acidemia cblB type Fulltext Access 5 Pages 2018
Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients Fulltext Access 5 Pages 2018
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation Fulltext Access 5 Pages 2018
Derivation and characterization of the NIH registry human stem cell line NYSCF101 under defined feeder-free conditions Fulltext Access 5 Pages 2018
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease Fulltext Access 5 Pages 2018
Establishment and characterization of a human embryonic stem cell line, NERCe002-A-3, with inducible 14-3-3ζ overexpression Fulltext Access 5 Pages 2018
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene Fulltext Access 5 Pages 2018
Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience Fulltext Access 5 Pages 2018
Generation of induced pluripotent stem cells from a patient with Best Dystrophy carrying 11q12.3 (BEST1 (VMD2)) mutation Fulltext Access 5 Pages 2018
Generation of the Rubinstein-Taybi syndrome type 2 patient-derived induced pluripotent stem cell line (IAIi001-A) carrying the EP300 exon 23 stop mutation c.3829Aâ¯>â¯T, p.(Lys1277*) Fulltext Access 5 Pages 2018
Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation Fulltext Access 5 Pages 2018
Generation of a human CDX2 knock-in reporter iPSC line (MHHi007-A-1) to model human trophoblast differentiation Fulltext Access 5 Pages 2018
Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708â¯Gâ¯>â¯C (W236C) missense mutation in exon 5 of the alpha-galactosidase-A gene Fulltext Access 5 Pages 2018
Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene Fulltext Access 5 Pages 2018
Establishment of a human iPSC line, IISHDOi004-A, from a patient with Usher syndrome associated with the mutation c.2276G>T; p.Cys759Phe in the USH2A gene Fulltext Access 5 Pages 2018
Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation Fulltext Access 5 Pages 2018
Generation of cytochrome P450 polymorphic human induced pluripotent stem cell lines with defective CYP activities Fulltext Access 5 Pages 2018
Reprint of: Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR Fulltext Access 5 Pages 2018
Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9 Fulltext Access 5 Pages 2018
Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene Fulltext Access 5 Pages 2018
A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing Fulltext Access 5 Pages 2018
Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823CÂ >Â T and EX6 del) in the PARK2 gene Fulltext Access 5 Pages 2018
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant Fulltext Access 5 Pages 2018
Generation of a luciferase-expressing human embryonic stem cell line: NERCe002-A-2 Fulltext Access 5 Pages 2018
Generation of a human iPSC line, IISHDOi002-A, with a 46, XY/47, XYY mosaicism and belonging to an African mitochondrial haplogroup Fulltext Access 5 Pages 2018
Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3 Fulltext Access 5 Pages 2018
Generation of a SMO homozygous knockout human embryonic stem cell line WAe001-A-16 by CRISPR/Cas9 editing Fulltext Access 5 Pages 2018
Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome Fulltext Access 5 Pages 2018
The effect on thrombin generation and anti-Xa levels of thromboprophylaxis dose adjustment in post-cesarean obese patients - A prospective cohort study Fulltext Access 6 Pages 2018
Lipoprotein apheresis affects lipoprotein particle subclasses more efficiently compared to the PCSK9 inhibitor evolocumab, a pilot study Fulltext Access 6 Pages 2018
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature Fulltext Access 6 Pages 2018
Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction Fulltext Access 6 Pages 2018
A Retrospective Study of Double-hit Lymphomas in Elderly Patients (Aged > 70 Years): Overall Outcomes Fulltext Access 6 Pages 2018
Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial Fulltext Access 6 Pages 2018
Basic coagulation tests as surrogates of dabigatran levels in a pre-operative setting: Analysis of five activated partial thromboplastin time reagents and thrombin time Fulltext Access 6 Pages 2018
In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems Fulltext Access 6 Pages 2018
FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products Fulltext Access 6 Pages 2018
Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation Fulltext Access 6 Pages 2018
Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome Fulltext Access 6 Pages 2018
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study Fulltext Access 6 Pages 2018
β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study Fulltext Access 6 Pages 2018
Fibrinolytic potential of DS-1040, a novel orally available inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) Fulltext Access 6 Pages 2018
Sub therapeutic rivaroxaban plasma concentrations following administration via Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes - A note of caution Fulltext Access 6 Pages 2018
Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation Fulltext Access 6 Pages 2018
The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma Fulltext Access 6 Pages 2018
Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants Fulltext Access 6 Pages 2018
Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial Fulltext Access 6 Pages 2018
Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study Fulltext Access 6 Pages 2018
Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications Fulltext Access 6 Pages 2018
Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome Fulltext Access 6 Pages 2018
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state Fulltext Access 6 Pages 2018
Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study Fulltext Access 6 Pages 2018
Evaluation of the quality of the reporting of phase II clinical trials in oncology: A systematic review Fulltext Access 6 Pages 2018
Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG Fulltext Access 6 Pages 2018
Development of apheresis techniques and equipment designed for patients weighing less than 10â¯kg Fulltext Access 6 Pages 2018
Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs Fulltext Access 6 Pages 2018